Regeneron pharmaceuticals, inc. sued for securities law violations - investors should contact levi & korsinsky for more information - regn

New york , feb. 11, 2025 /prnewswire/ -- levi & korsinsky, llp notifies investors in regeneron pharmaceuticals, inc. ("regeneron" or the "company") (nasdaq: regn) of a class action securities lawsuit. class definition: the lawsuit seeks to recover losses on behalf of regeneron investors who were adversely affected by alleged securities fraud between november 2, 2023 and october 30, 2024.
REGN Ratings Summary
REGN Quant Ranking